VYMADA 200MG Tablet is a prescription medicine that combines Sacubitril and Valsartan, belonging to the class of angiotensin receptor-neprilysin inhibitors (ARNI). It is recommended for patients with chronic heart failure (NYHA Class II–IV) with reduced ejection fraction to help lower the chances of cardiovascular death and hospital admissions. By improving heart function and reducing stress on the heart, VYMADA 200MG Tablet supports better long-term outcomes in individuals already on standard heart failure therapies.
VYMADA 200MG Tablet can be taken with or without food, preferably at the same time each day for consistent results. The dosage and frequency will be decided by your doctor based on your health condition and response to the medicine. It is important to continue taking the tablet regularly as prescribed and avoid missing doses to achieve the best outcomes. Do not discontinue the medication on your own, even if you feel better, as ongoing use helps maintain heart function and lowers the chances of future health risks.
Common side effects of VYMADA 200MG Tablet may include low blood pressure (hypotension), changes in kidney function, increased potassium levels (hyperkalemia), cough, nausea, and dizziness. To minimize dizziness linked with a drop in blood pressure, rise slowly when moving from a sitting or lying position. Inform your doctor if any of these side effects persist, become bothersome, or if you notice other unusual symptoms.
Before using VYMADA 200MG Tablet, inform your doctor if you are taking any medicines for blood pressure, heart conditions, kidney problems, or liver disorders. Share a complete list of your ongoing medications, as some may interact with this tablet. VYMADA 200MG Tablet should not be used during pregnancy and is not recommended while breastfeeding. During therapy, your doctor may suggest regular monitoring of blood pressure, kidney function, and overall health status to ensure safe and effective use.
No content available
